Bemis Acquisition: Why I Actually Trust Them More Now

I Was Skeptical When Amcor Bought Bemis. Here's What Changed My Mind.

When I first heard about the Amcor acquisition of Bemis, my reaction wasn't excitement. It was worry. I've been in procurement long enough—since 2020, actually—to have seen big acquisitions go sideways. The small supplier you depend on gets absorbed, service drops, prices creep up, and you're left scrambling for alternatives.

Look, I'm not saying I was right to be worried. But after what I've seen with other vendors who got bought out, I had a shortlist of fears: reduced flexibility, longer lead times, and that vague "pricing realignment" that always seems to follow. So when my management mentioned Amcor Bemis as a potential primary supplier for our medical device packaging, I had reservations.

I was wrong.

Not completely wrong—some of my fears were valid—but mostly wrong about what the acquisition meant for us as a customer. Here's why.

What I Got Wrong About the Amcor-Bemis Merger

My initial assumption was that Bemis would lose its niche expertise. A big conglomerate buying a specialist—you've seen it before. The specialist gets absorbed into the machine, its unique capabilities get diluted, and eventually you're just another account number.

But here's the thing: Bemis's core business — healthcare packaging — is not something you can just slot into a generic division. It requires dedicated manufacturing lines, specific regulatory certifications (like ISO 13485), and deep material science knowledge. From what I've seen over the past two years of working with them, Amcor's strategy seems to be letting Bemis operate as a specialized unit within a larger network.

What that means practically: we still deal with the same Bemis team. The same technical support. The same quality standards. But now we've got the backing of a global supply chain behind us.

Not ideal, but workable. Actually, better than workable.

The Real Value: Manufacturing Scale Without Sacrificing Specialization

I manage ordering for a mid-sized medical device company—about 400 employees across two locations. We process roughly 70-80 order lines annually for packaging alone, across 5-6 vendors. Our spend in this category? Around $200,000 annually. And that's just for the standard stuff.

What I've seen with Bemis post-acquisition: they've maintained their focus on the medical and industrial segments while giving us access to Amcor's broader material portfolio. We needed a custom laminate for a poster outlining sterilization instructions—not exactly their standard line. Before, I'd have had to source it separately. Now? Their team picked it up as a single order.

That said, I should clarify: not everything is rainbows. Integrating two companies is messy. There were a few months in 2023 where order tracking was inconsistent. I had to call twice on one shipment because their systems were still syncing. Frustrating? Yes. But I'll take a messy integration over a hollowed-out specialist any day.

The most frustrating part of vendor transitions: dealing with companies that promise "seamless" everything. You'd think a $6 billion acquisition would come with a flawless handover, but the reality is always more complicated.

What ultimately sold me: their willingness to say "this isn't our strength."

Why "We're Not the Best Fit" Earned My Trust

I once asked them about handling a very specific sharps container configuration—one we use for a niche surgical kit. Instead of the usual "yes, we can do that," the rep paused and said: "Our standard line would work, but for that exact spec, you'd be better off with a smaller specialist. Here's who I'd call."

That moment, for me, was the trust builder. A vendor who knows their boundaries is a vendor I can rely on for everything they do claim expertise in. I don't want a one-stop shop that's mediocre across the board. I want a supplier who's excellent where it matters and honest where it doesn't.

This is the "expertise boundary" philosophy in action: Bemis knows medical packaging. They're excellent at it. They're not pretending to be the best at everything, and that's refreshing in a market where every company claims to be the "comprehensive solution."

To be fair: price is still a factor. They're not the cheapest option out there. If all you need is basic commodity packaging, there are cheaper alternatives. But if you're in healthcare, medical devices, or any regulated industry where packaging matters—where a failure means compliance issues or worse—the premium is justified.

What Changed After the Acquisition: A Practical Breakdown

Here's a quick reality check based on my experience. It's accurate as of late 2024, though the market moves fast, so verify current terms before budgeting.

• Product range: Expanded. We now have access to Amcor's flexible packaging lines alongside Bemis's rigid and specialty medical packaging. More options from a single relationship.
• Lead times: Slightly improved, thanks to Amcor's global supply chain. We've seen 1-2 week reductions on standard items, though custom orders still take their time.
• Pricing: Stable. I haven't seen the post-acquisition price hike I feared. Actually, we consolidated volume and saved ~8% compared to splitting orders between Bemis and another Amcor division separately.
• Service: A minor dip during integration (2023 Q2-Q3), but back to pre-acquisition levels now. The same technical team, same quality support.

One data point I track: we had a rush order for a sterilization pouch laminate in Q4 2024. The delivery window was tight—10 business days. It arrived in 8. Was that lucky timing or a systemic improvement? Hard to say. But it's the kind of outcome that builds confidence.

So here's my bottom line.

Final Take: The Acquisition Was a Win for Buyers Like Me

I get why some people are skeptical of big-company acquisitions. I was one of them. But the Amcor-Bemis merger is an example of it working—because Amcor didn't try to absorb Bemis and turn it into a generic division. They kept the specialist intact and gave it a bigger platform.

Will this hold forever? I can't predict that. Corporate strategy changes. But for now, as someone managing procurement for real, operational needs—with budgets, timelines, and compliance requirements—I'd rather work with a focused partner backed by strong infrastructure than a generalist who overpromises and underwhelms.

What I mean is: if you're in healthcare or industrial packaging and you're evaluating suppliers, don't write off Bemis just because they got acquired. The specialist is still there. Probably better equipped than before. And worth a conversation—especially if you value expertise that knows its own boundaries.